Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

¥9.88As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300534Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.41%)
Div yield 0.40%
ROE 5.85%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.37
PE TTM 122.0
TSR TTM (1.65%)
Mkt cap ¥2.997B
ROIC 4.94%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥10
6.11%
(60.48%)
Hold 9|2|9|8|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.15
0.15
0.16
9.17%
3.17%
(7.11%)
0.58%
Revenue¥M
214.9
227.7
223.9
234.5
17.85%
19.02%
15.46%
14.77%
Peers (US$449.3M)
Cap (US$)
PE
448.7M
16.25x
436.6M
—
450.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.412
1.041
0.823
EBIT/Intx
1.071
0.101
0.107
Own earn%
(225.16)
5.89
(8.55)
Sh yield%
35.66
44.39
41.67
Owners
Insiders/Inst%
6.37
68.02
Short interest%
2.98
SBC / revenue%
0.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
23–26
$1 testx
0.0
Incr. ROIC%
6